A federal judge has outlined a discovery plan that will begin immediately, focusing on general causation about whether prenatal exposure to Tylenol causes autism and ADHD
Plaintiffs will now be able to file Tylenol autism and ADHD lawsuits directly in the federal MDL court, using a standardized form that will help the Court and parties evaluate information about each claim
Census of all Tylenol lawsuits being pursued for children diagnosed with autism and ADHD may influence plans for pretrial discovery and early bellwether trials, which may facilitate early settlements
Stream-lined process for filing future Tylenol lawsuits over autism and ADHD caused by exposure to acetaminophen during pregnancy will allow the Court to coordinate the claims and allegations being pursued
Walmart claims the FDA has specific rules which would prevent it from adding the acetaminophen pregnancy warnings plaintiffs claim were missing from the pain killers
Despite years of scientific evidence, Walmart failed to add autism warnings to its painkillers' labels, the Equate acetaminophen lawsuit claims
Court appointed lawyers will take certain actions during the federal Tylenol autism MDL that benefit all families presenting a claim against the makers of acetamiophen
Walmart tried to dismiss two lawsuits filed by mothers who say they used the retailer's Equate acetaminophen tablets during pregnancy, resulting in their children being born with autism and ADHD
The plaintiffs' attorneys will take actions which will benefit all families pursuing a Tylenol lawsuit over ADHD or autism caused by acetaminophen-based pain medications used during pregnancy
Judge has set a deadline of November 14, 2022 for acetaminopen lawyers seeking leadership positions in the litigation to submit applications for Co-Lead and Liaison Counsel
